Translating breakthrough science into breakthrough therapeutics

Investors

ASX Annoucements

Click here to View all future announcements via ASX: PYC therapeutics Limited

2020

2019

Media Release

07/05/2020 - Successful world class results announced for Retinitis Pigmentosa

2019 OTS Conference PYC Poster

2019 OTS Conference Janya Grainok (PYC Collaborator) Poster

03/10/2019 - Media Release

Corporate Governance

Phylogica Limited (“Company”) has adopted a Corporate Governance Plan which forms the basis of a comprehensive system of control and accountability for the administration of corporate governance.

The Board is committed to administering the policies and procedures with openness and integrity, pursuing the true spirit of corporate governance commensurate with the Company’s needs.

To the extent they are applicable to the Company, the Board has adopted the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations 3rd Edition (“Principles & Recommendations”).

A Corporate Governance Statement sets out details of the Company’s compliance with the Principles & Recommendations. Click here to read the ASX Corporate Governance Principles & Recommendations.

The Company is pleased to make the following information on its corporate governance practices available on this website.

Click to view the latest Corporate Governance Statement

Constitution - PYC Therapeutics Limited

Constitution - Phylogica Limited

Charters

Board

Audit Committee

Risk Committee

Nomination Committee

Remuneration Committee

Policies & Procedures

Corporate Code of Conduct

Disclosure - Performance Evaluation

Disclosure - Continuous Disclosure

Disclosure - Risk Management

Whistleblower Policy

Trading Policy

Diversity Policy

Shareholder Communication Strategy

Definition of Independence

Appendix 4G

Subscribe to our mailing list